Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2023 Annual Meeting | C46 - Cognitive, Behavioral, and Disease-modifying Therapeutics in Dementia

Sunday 04/23/23
01:00 PM - 03:00 PM EST Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Seminar
Meredith Wicklund, MD, FAAN
Aging, Dementia, Cognitive, and Behavioral Neurology
Participants should become familiar with the indication for and clinical utility of pharmacological and non-pharmacological therapeutics for dementia related cognitive and behavioral symptoms, and become familiar with the first ever disease modifying treatments for dementia and their role in clinical practice.
2.00 CME credits
Patient Care & Procedural Skills, Medical Knowledge, Systems-based Practice
Introductory
Advanced Practice Provider
Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student
Case-based, Didactic, Audience Participation

Program Materials Program Evaluations

Event Timeline
01:00 PM - 01:35 PM EST Speaker Nonpharmacological Treatment of Behavioral Symptoms in Dementia
Julio C. Rojas-Martinez, MD, PhD
01:35 PM - 02:10 PM EST Speaker Pharmacological Treatment of Cognitive and Behavioral Symptoms in Dementia
Lealani Mae Acosta, MD, FAAN
02:10 PM - 02:45 PM EST Speaker Disease Modifying Therapeutics in Dementia
Meredith Wicklund, MD, FAAN
02:45 PM - 03:00 PM EST Discussion Questions and Answers
Meredith Wicklund, MD, FAAN, Julio C. Rojas-Martinez, MD, PhD, Lealani Mae Acosta, MD, FAAN
Faculty Disclosures
Lealani Mae Acosta, MD, FAAN Dr. Acosta has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. The institution of Dr. Acosta has received research support from AbbVie, Biohaven, Roche, NIH.
Meredith Wicklund, MD, FAAN The institution of Dr. Wicklund has received research support from Arizona Alzheimer's Consortium. The institution of Dr. Wicklund has received research support from NIH.
Julio C. Rojas-Martinez, MD, PhD The institution of Dr. Rojas-Martinez has received research support from NIH/NIA. The institution of Dr. Rojas-Martinez has received research support from Eli Lilly. The institution of Dr. Rojas-Martinez has received research support from Eisai.